Uflex Ltd Q1 FY2026 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/tsepieytrup66ynoxbapi5yq.pdf

Key Takeaways


The Jindal Fire: A Supply-Side Inflection

Rajesh Bhatia: "a very large player in the packaging film industry had an accident at its plant and that changed the industry dynamics a bit"

Overseas Operations: Tariff Turbulence

Rajesh Bhatia: "a large part of our exports from Mexico to US are covered under USMCA and there is a nil duty as of now. And if that remains so, that will ultimately give us an edge over the other countries who were selling to US"

Aseptic Packaging: Delayed Again, Guidance Cut

Rajesh Bhatia: "even if it gets done tomorrow itself, it is not going to give you any additional revenue than the profitability as of now"

CAPEX Pipeline: Heavy, Back-End Loaded

Rajesh Bhatia: "But I think it is a game of patience because the government is doing this, now see this is the first year, next year when the government will audit it or people will file their returns then it will be known how they are taking this thing, how they are doing it."

Margins & Costs: Pressure Points


Industry Structure & Competitive Dynamics

Rajesh Bhatia: "We have seen that whenever some margins increase then everyone who is there in the industry everyone says that I should also make one line at least. Like everyone has done last time, if this happens like that then again, we will go to overcapacity in the next three years."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth10% YoY increase; remaining three quarters need ~11% growth, partly volume but largely pricingFY26
EBITDA~₹2,100 crores (vs ~₹1,900 crores in FY25)FY26
Aseptic packaging volume850-900 crore packs (revised from ~1,000 crore packs)FY26
Aseptic expansion commissioningLatest early H2 FY26; revenue benefit only from January 2026Early H2 FY26
Egypt aseptic greenfield commissioningLikely in FY26; product approval takes additional timeFY26
Film division production~132,000 tons per quarterFY26 quarterly run-rate
CAPEX balance spend~₹900 croresFY26 and Q1 FY27
Net debt-to-EBITDA peak4.0-4.1x, then declining below 3x as projects commissionPeak during project phase
CAPEX project revenue/EBITDA contribution~₹3,000 crores revenue, ~₹600 crores EBITDA at 85% utilizationFY27 (bulk of benefit)
Sanand expansion benefitFrom January 2026January 2026 onward
Noida recycling facilityReady by end of year; regulatory traction may take 1-2 extra yearsFacility: FY26; benefit: gradual
Nigeria and Poland utilization recoveryExpected to sort outNext couple of quarters
US tariff situation clarityNeeds to settle before final plans are clearNext two quarters

Key Metrics

MetricQ1 FY26
Revenue₹3,922 cr, up ~6.5% YoY
Volume growth7.9% YoY, excluding PET resin sales
Packaging films volume growth6.8% YoY
Packaging (flexible) volume growth11.7% YoY
EBITDA margin12.0%, down from 12.7% in Q1 FY25
Exceptional forex lossNil, versus ~₹180 cr in Q1 FY25
Flexible Packaging volume growth7.4% YoY
Liquid Packaging volume growth18% YoY
Asepto volume230 cr packs, Q1 FY26
Asepto FY26 volume guidance850–900 cr packs, revised from ~1,000 cr packs
Film division production volume127,900 tons, Q1 FY26
Film division quarterly production guidance~132,000 tons per quarter
India PET resin capacity utilization97%
Egypt PET resin capacity utilization~75%
Net debt-to-EBITDA3.90x, expected to peak at 4.1x
Total debt₹7,300 cr
CAPEX spent as of June 30~₹1,100 cr out of ~₹2,000 cr approved
FY26 revenue growth guidance10% YoY; Q1 grew 6.4%, remaining 3 quarters need ~11% growth
FY26 EBITDA guidance~₹2,100 cr, versus ~₹1,900 cr in FY25
New projects potential revenue~₹3,000 cr at ~85% utilization
New projects potential EBITDA~₹600 cr, implying ~20% margin
BOPP gross value-added margin~35% over raw material cost